Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL425 in healthy adults for H1N1 influenza
NCT00958126Phase 2Completed
- Sponsor
- CSL Seqirus
- Start
- Aug 2009
- Primary completion
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CSL H1N1 Pandemic Influenza Vaccine in Influenza A H1N1 (H1N1), sponsored by CSL Seqirus. Started Aug 2009; status: completed.
02
Drugs
CSL H1N1 Pandemic Influenza Vaccine
03
Conditions
Influenza A H1N1 (H1N1)
Beyond the preview
Go deeper on NCT00958126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958126.